Corvus Pharmaceuticals, Inc is a biotechnology business based in the US. Corvus Pharmaceuticals shares (CRVS) are listed on the NASDAQ and all prices are listed in US Dollars. Corvus Pharmaceuticals employs 42 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Corvus Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CRVS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Corvus Pharmaceuticals stock price (NASDAQ: CRVS)Use our graph to track the performance of CRVS stocks over time.
Corvus Pharmaceuticals shares at a glance
|Latest market close||$2.74|
|52-week range||$2.07 - $5.08|
|50-day moving average||$2.63|
|200-day moving average||$3.10|
|Wall St. target price||$7.38|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.56|
Buy Corvus Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Corvus Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Corvus Pharmaceuticals price performance over time
|1 week (2021-07-14)||N/A|
|1 month (2021-06-25)||-3.52%|
|3 months (2021-04-21)||N/A|
|6 months (2021-01-21)||N/A|
|1 year (2020-07-21)||N/A|
|2 years (2019-07-21)||N/A|
|3 years (2018-07-21)||N/A|
|5 years (2016-07-21)||N/A|
Corvus Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-28.67%|
|Return on equity TTM||-6.01%|
|Market capitalisation||$90 million|
TTM: trailing 12 months
Shorting Corvus Pharmaceuticals shares
There are currently 1.2 million Corvus Pharmaceuticals shares held short by investors – that's known as Corvus Pharmaceuticals's "short interest". This figure is 6.7% up from 1.1 million last month.
There are a few different ways that this level of interest in shorting Corvus Pharmaceuticals shares can be evaluated.
Corvus Pharmaceuticals's "short interest ratio" (SIR)
Corvus Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Corvus Pharmaceuticals shares currently shorted divided by the average quantity of Corvus Pharmaceuticals shares traded daily (recently around 173022.74678112). Corvus Pharmaceuticals's SIR currently stands at 6.99. In other words for every 100,000 Corvus Pharmaceuticals shares traded daily on the market, roughly 6990 shares are currently held short.
However Corvus Pharmaceuticals's short interest can also be evaluated against the total number of Corvus Pharmaceuticals shares, or, against the total number of tradable Corvus Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Corvus Pharmaceuticals's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Corvus Pharmaceuticals shares in existence, roughly 30 shares are currently held short) or 0.0652% of the tradable shares (for every 100,000 tradable Corvus Pharmaceuticals shares, roughly 65 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Corvus Pharmaceuticals.
Find out more about how you can short Corvus Pharmaceuticals stock.
Corvus Pharmaceuticals share dividends
We're not expecting Corvus Pharmaceuticals to pay a dividend over the next 12 months.
Corvus Pharmaceuticals share price volatility
Over the last 12 months, Corvus Pharmaceuticals's shares have ranged in value from as little as $2.07 up to $5.08. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Corvus Pharmaceuticals's is 1.6496. This would suggest that Corvus Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Corvus Pharmaceuticals overview
Corvus Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is CPI-006, an anti-CD73 monoclonal antibody, which is in Phase I/Ib clinical trial that inhibits the production of adenosine and activate various immune cells, as Phase III clinical trial of CPI-006 for COVID-19. The company also develops CPI-818, a covalent inhibitor of ITK, which is in Phase I/Ib clinical trial to treat patients with various malignant T-cell lymphomas; and Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor that is in Phase Ib/II clinical trial for adenosine, an immune checkpoint. Its preclinical stage products include CPI-182, an antibody to block neutrophil function and migration, and myeloid derived suppressor cells; and CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a strategic collaboration with Angel Pharmaceuticals for the development its pipeline of targeted investigational medicines.
Stocks similar to Corvus Pharmaceuticals
Corvus Pharmaceuticals in the news
SA Marketplace 2021 Top Idea Contest: Mid-Year Update
Down 15.8% in 4 Weeks, Here's Why Corvus (CRVS) Looks Ripe for a Turnaround
Corvus Pulls Plug On Mupadolimab COVID-19 Program With Candidate Now Prioritized In Oncology
Frequently asked questionsWhat percentage of Corvus Pharmaceuticals is owned by insiders or institutions?
Currently 4.3% of Corvus Pharmaceuticals shares are held by insiders and 62.811% by institutions. How many people work for Corvus Pharmaceuticals?
Latest data suggests 42 work at Corvus Pharmaceuticals. When does the fiscal year end for Corvus Pharmaceuticals?
Corvus Pharmaceuticals's fiscal year ends in December. Where is Corvus Pharmaceuticals based?
Corvus Pharmaceuticals's address is: 863 Mitten Road, Burlingame, CA, United States, 94010 What is Corvus Pharmaceuticals's ISIN number?
Corvus Pharmaceuticals's international securities identification number is: US2210151005 What is Corvus Pharmaceuticals's CUSIP number?
Corvus Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 221015100
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert